These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 34326776)

  • 1. Elevated Levels of Soluble Axl (sAxl) Regulates Key Angiogenic Molecules to Induce Placental Endothelial Dysfunction and a Preeclampsia-Like Phenotype.
    Gui S; Zhou S; Liu M; Zhang Y; Gao L; Wang T; Zhou R
    Front Physiol; 2021; 12():619137. PubMed ID: 34326776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma concentrations of sAxl are associated with severe preeclampsia.
    Liu X; Gong Y; Jia J; Bai Y; Gui S; Wang T; Zhou R
    Clin Biochem; 2014 Feb; 47(3):173-6. PubMed ID: 24239956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma levels of TAM receptors and ligands in severe preeclampsia.
    Peng S; Sun M; Sun X; Wang X; Jin T; Wang H; Han C; Meng T; Li C
    Pregnancy Hypertens; 2018 Jul; 13():116-120. PubMed ID: 30177037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibiting trophoblast PAR-1 overexpression suppresses sFlt-1-induced anti-angiogenesis and abnormal vascular remodeling: a possible therapeutic approach for preeclampsia.
    Zhao Y; Zheng Y; Liu X; Luo Q; Wu D; Liu X; Zou L
    Mol Hum Reprod; 2018 Mar; 24(3):158-169. PubMed ID: 29325127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: A pragmatic guide for first-trimester screening and prevention.
    Poon LC; Shennan A; Hyett JA; Kapur A; Hadar E; Divakar H; McAuliffe F; da Silva Costa F; von Dadelszen P; McIntyre HD; Kihara AB; Di Renzo GC; Romero R; D'Alton M; Berghella V; Nicolaides KH; Hod M
    Int J Gynaecol Obstet; 2019 May; 145 Suppl 1(Suppl 1):1-33. PubMed ID: 31111484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitamin D Supplementation Prevents Placental Ischemia Induced Endothelial Dysfunction by Downregulating Placental Soluble FMS-Like Tyrosine Kinase-1.
    Ma SL; Tian XY; Wang YQ; Zhang HF; Zhang L
    DNA Cell Biol; 2017 Dec; 36(12):1134-1141. PubMed ID: 28981319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A longitudinal study of circulating angiogenic and antiangiogenic factors and AT1-AA levels in preeclampsia.
    Sahay AS; Patil VV; Sundrani DP; Joshi AA; Wagh GN; Gupte SA; Joshi SR
    Hypertens Res; 2014 Aug; 37(8):753-8. PubMed ID: 24718301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between adverse pregnancy outcome and imbalance in angiogenic regulators and oxidative stress biomarkers in gestational hypertension and preeclampsia.
    Turpin CA; Sakyi SA; Owiredu WK; Ephraim RK; Anto EO
    BMC Pregnancy Childbirth; 2015 Aug; 15():189. PubMed ID: 26303772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maternal plasma from pregnant women with umbilical placental vascular disease does not affect endothelial cell mRNA expression of nitric oxide synthase.
    Wang X; Athayde N; Trudinger B
    J Soc Gynecol Investig; 2004 Apr; 11(3):149-53. PubMed ID: 15051034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defective trophoblast invasion underlies fetal growth restriction and preeclampsia-like symptoms in the stroke-prone spontaneously hypertensive rat.
    Barrientos G; Pussetto M; Rose M; Staff AC; Blois SM; Toblli JE
    Mol Hum Reprod; 2017 Jul; 23(7):509-519. PubMed ID: 28402512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo uteroplacental release of placental growth factor and soluble Fms-like tyrosine kinase-1 in normal and preeclamptic pregnancies.
    Holme AM; Roland MC; Henriksen T; Michelsen TM
    Am J Obstet Gynecol; 2016 Dec; 215(6):782.e1-782.e9. PubMed ID: 27503620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extracellular Vesicles From Women With Severe Preeclampsia Impair Vascular Endothelial Function.
    Murugesan S; Hussey H; Saravanakumar L; Sinkey RG; Sturdivant AB; Powell MF; Berkowitz DE
    Anesth Analg; 2022 Apr; 134(4):713-723. PubMed ID: 34871190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Placental-Specific sFLT-1 e15a Protein Is Increased in Preeclampsia, Antagonizes Vascular Endothelial Growth Factor Signaling, and Has Antiangiogenic Activity.
    Palmer KR; Kaitu'u-Lino TJ; Hastie R; Hannan NJ; Ye L; Binder N; Cannon P; Tuohey L; Johns TG; Shub A; Tong S
    Hypertension; 2015 Dec; 66(6):1251-9. PubMed ID: 26416849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Restoring placental growth factor-soluble fms-like tyrosine kinase-1 balance reverses vascular hyper-reactivity and hypertension in pregnancy.
    Zhu M; Ren Z; Possomato-Vieira JS; Khalil RA
    Am J Physiol Regul Integr Comp Physiol; 2016 Sep; 311(3):R505-21. PubMed ID: 27280428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel peptide relieves endothelial cell dysfunction in preeclampsia by regulating the PI3K/mTOR/HIF1α pathway.
    Xue L; Xie K; Wu L; Yu X; Long W; Li C; Jia R; Ding H
    Int J Mol Med; 2021 Jan; 47(1):276-288. PubMed ID: 33236147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combining Biomarkers to Predict Pregnancy Complications and Redefine Preeclampsia: The Angiogenic-Placental Syndrome.
    Stepan H; Hund M; Andraczek T
    Hypertension; 2020 Apr; 75(4):918-926. PubMed ID: 32063058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relationship between circulating endothelin-1, soluble fms-like tyrosine kinase-1 and soluble endoglin in preeclampsia.
    Aggarwal PK; Chandel N; Jain V; Jha V
    J Hum Hypertens; 2012 Apr; 26(4):236-41. PubMed ID: 21451568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. OS076. The effect of lectin-like oxidized low density lipoprotein receptor monoclonal antibody (LOX-1 MAb) on the expression of eNOS in preeclamptic HUVECs model.
    Keman K; Rahardjo B; Madakusuma D
    Pregnancy Hypertens; 2012 Jul; 2(3):218-9. PubMed ID: 26105290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Placental growth factor reverses decreased vascular and uteroplacental MMP-2 and MMP-9 and increased MMP-1 and MMP-7 and collagen types I and IV in hypertensive pregnancy.
    Ren Z; Cui N; Zhu M; Khalil RA
    Am J Physiol Heart Circ Physiol; 2018 Jul; 315(1):H33-H47. PubMed ID: 29569955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sulfasalazine reduces placental secretion of antiangiogenic factors, up-regulates the secretion of placental growth factor and rescues endothelial dysfunction.
    Brownfoot FC; Hannan NJ; Cannon P; Nguyen V; Hastie R; Parry LJ; Senadheera S; Tuohey L; Tong S; Kaitu'u-Lino TJ
    EBioMedicine; 2019 Mar; 41():636-648. PubMed ID: 30824385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.